BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma
Crossref DOI link: https://doi.org/10.1038/onc.2015.264
Published Online: 2015-07-06
Published Print: 2016-04-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hagenbuchner, J
Kiechl-Kohlendorfer, U
Obexer, P
Ausserlechner, M J
Text and Data Mining valid from 2015-07-06
Version of Record valid from 2015-07-06
Article History
Received: 3 February 2015
Revised: 3 June 2015
Accepted: 6 June 2015
First Online: 6 July 2015
Competing interests
: The authors declare no conflict of interest.